Alzamend Neuro (ALZN) Share-based Compensation (IS) (2020 - 2022)
Alzamend Neuro's Share-based Compensation (IS) was $715,639 in fiscal Q2 2023 (quarter ended Oct 31, 2022), down 44.1% from $1.28 million a year earlier and down 17.5% from the prior quarter.
Alzamend Neuro (ALZN) Share-based Compensation (IS) (2020 - 2022) Analysis & Trends
On a trailing twelve-month basis, Alzamend Neuro's Share-based Compensation (IS) was $3.97 million through Oct 31, 2022, up 21.4% year-over-year; for FY2022 (ended Apr 30, 2022), it was $4.41 million, up 82.8% from FY2021.
- In earlier fiscal years, Share-based Compensation (IS) was $2.41 million in FY2021.
- The fiscal Q2 2023 figure marks the lowest quarterly Share-based Compensation (IS) since fiscal Q4 2021.
- Compared with a year earlier, Share-based Compensation (IS) was higher in four of the last five quarters, with growth averaging 36.2%.
- Per Business Quant data, ALZN's Share-based Compensation (IS) in the three fiscal quarters before Q2 2023 was $867,338 (Q1 2023), $1.26 million (Q4 2022) and $1.13 million (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Alzamend Neuro | 5.73 Mn | -9.73 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2022 | 715,639.00 |
| Jul 31, 2022 | 867,338.00 |
| Apr 30, 2022 | 1.26 Mn |
| Jan 31, 2022 | 1.13 Mn |
| Oct 31, 2021 | 1.28 Mn |
| Jul 31, 2021 | 739,622.00 |
| Apr 30, 2021 | 675,566.00 |
| Jan 31, 2021 | 575,127.00 |
| Jul 31, 2020 | 591,433.00 |
Alzamend Neuro Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();